Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals
Public Health Journal · 15.11.2026 · 3 (4) · 1463-1473
DOI: 10.62710/2a3pcv48 ↗Kurz gefasst
Fachartikel in der Zeitschrift Public Health Journal, online erschienen am 15.11.2026. Verfasst von Adi Setiadi.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is a problem in pharmacology so marine bioactive compounds were studied as hepatoprotective candidates. This study evaluated fucoidan from brown seaweed against paracetamol liver injury in Wistar mice. The 30 male mice were divided into five groups: normal control, DILI control, comparator control receiving silymarin, and fucoidan group at doses of 100 and 300 mg/kg/day orally for 14 days. Exposure to paracetamol increased levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, bilirubin, and liver malondialdehyde compared to normal controls. Fucoidan at a dose of 300 mg/kg reduced ALT and AST by 35% and 31%, respectively, and improved liver antioxidant and histological status compared to the DILI control. These findings show the potential of fucoidan in protecting the liver and require further research related to its pharmacology and safety.
Zitieren
APA
Setiadi, A. (2026). Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals. Public Health Journal, 3(4), 1463-1473. https://doi.org/10.62710/2a3pcv48
Vancouver
Setiadi A. Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals. Public Health Journal. 2026;3(4):1463-1473. doi:10.62710/2a3pcv48
BibTeX
@article{Setiadi2026,
author = {Setiadi, Adi},
title = {Hepatoprotective Effects of Marine Derived Bioactive Compounds against Drug Induced Liver Injury in Experimental Animals},
journal = {Public Health Journal},
year = {2026},
volume = {3},
number = {4},
pages = {1463--1473},
doi = {10.62710/2a3pcv48}
}
EUVIMED